Group One Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,432
Closed -$118K 9275
2024
Q3
$105K Sell
1,432
-5,209
-78% -$391K ﹤0.01% 4139
2024
Q2
$455K Sell
6,641
-964
-13% -$66.9K 0.01% 2651
2024
Q1
$526K Sell
7,605
-5,913
-44% -$406K 0.02% 2675
2023
Q4
$968K Buy
+13,518
New +$778K 0.03% 2480
2023
Q1
Sell
-6,984
Closed -$338K 9158
2022
Q4
$370K Buy
6,984
+5,534
+382% +$277K 0.01% 3318
2022
Q3
$67K Buy
+1,450
New +$75.7K ﹤0.01% 5155
2022
Q1
Sell
-9,541
Closed -$495K 9804
2021
Q4
$499K Sell
9,541
-18,087
-65% -$760K 0.01% 4134
2021
Q3
$1.03M Buy
27,628
+15,834
+134% +$550K 0.02% 3379
2021
Q2
$481K Sell
11,794
-2,190
-16% -$81K 0.01% 4256
2021
Q1
$474K Buy
+13,984
New +$485K 0.01% 4098
2020
Q4
Sell
-16,132
Closed -$424K 7838
2020
Q3
$414K Sell
16,132
-56,221
-78% -$1.28M 0.02% 3013
2020
Q2
$1.86M Buy
+72,353
New +$1.46M 0.11% 1516
2019
Q4
Sell
-53,244
Closed -$639K 6359
2019
Q3
$398K Buy
+53,244
New +$511K 0.04% 2528
2019
Q1
Sell
-19,561
Closed -$250K 6017
2018
Q4
$223K Sell
19,561
-33,980
-63% -$549K 0.02% 2602
2018
Q3
$1.16M Sell
53,541
-15,145
-22% -$317K 0.08% 1585
2018
Q2
$1.21M Sell
68,686
-5,995
-8% -$122K 0.09% 1529
2018
Q1
$1.57M Buy
74,681
+16,499
+28% +$321K 0.13% 1177
2017
Q4
$842K Buy
58,182
+20,096
+53% +$310K 0.04% 1856
2017
Q3
$601K Buy
38,086
+24,316
+177% +$357K 0.04% 1934
2017
Q2
$171K Buy
13,770
+9,458
+219% +$110K 0.01% 2758
2017
Q1
$70K Sell
4,312
-523
-11% -$7.57K 0.01% 3206
2016
Q4
$73K Sell
4,835
-1,611
-25% -$22.8K ﹤0.01% 3025
2016
Q3
$98K Buy
+6,446
New +$261K 0.01% 2936
2016
Q2
Sell
-17,534
Closed -$630K 5446
2016
Q1
$487K Buy
17,534
+4,001
+30% +$133K 0.05% 1705
2015
Q4
$728K Buy
13,533
+1,242
+10% +$62.6K 0.06% 1539
2015
Q3
$492K Buy
12,291
+3,760
+44% +$123K 0.05% 1797
2015
Q2
$273K Buy
+8,531
New +$216K 0.02% 2302

Other funds holding ITCI